FIGURE

Figure 4

ID
ZDB-FIG-230314-30
Publication
Zhou et al., 2023 - The apatinib and pemetrexed combination has antitumor and antiangiogenic effects against NSCLC
Other Figures
All Figure Page
Back to All Figure Page
Figure 4

Co-administration of apatinib and pemetrexed inhibited tumor growth in vivo. (a) DiI-stained human A549 cells were successfully grafted into the yolk sac of a zebrafish embryo 2 dpf without immunosuppressant treatment. Approximately 200 cells were injected into the yolk sac and assessed by fluorescence microscopy. (b) Tumor growth at 4 dpi was observed by fluorescence microscopy. (c) Quantitative analysis of inhibitory effects of Apatinib, Pemetrexed, or combination concerning tumor growth. Columns, mean; bars, SEM (n = 10; ANOVA; ***P < 0.0001, **P < 0.01, *P < 0.05, compared to vehicle control group; *P < 0.05, compared to combination group). RFI, relative fluorescence intensity; dpi, days post-injection; MNLC, maximum non-lethal concentration. Zebrafish Strain: fli1a-EGFP; casper. Route of Administration: Soaking in 0.1% DMSO (in fish water).

Expression Data

Expression Detail
Antibody Labeling
Phenotype Data

Phenotype Detail
Acknowledgments
This image is the copyrighted work of the attributed author or publisher, and ZFIN has permission only to display this image to its users. Additional permissions should be obtained from the applicable author or publisher of the image. Full text @ Open Life Sci